Intero Biosystems
Intero Biosystems

Intero Biosystems

DR22Ahrefs DR: 22/100. Below median. Measured by Ahrefs. Median 44.eDR100Effective DR: 100/100. Top 25%. Measured by StartupHub.ai. Median 68.Agent39Agent Readiness: 39/100. Below median. Measured by StartupHub.ai. Median 41.Speed50Site Speed: 50/100. Below median. Measured by Google PageSpeed. Median 62.

Intero Biosystems develops human intestinal organoid platforms for drug discovery, aiming to improve preclinical testing and reduce animal reliance.

Website
2024ActiveAnn Arbor, United States

About

Intero Biosystems is a biotechnology startup that creates advanced adult human stem cell-derived intestinal organoid platforms for drug discovery and development. Their flagship product, GastroScreen, is a 'mini-gut in a dish' that accurately mimics the human intestine, including key cell types, functional smooth muscle, blood vessels, and neurons. This technology enables comprehensive safety and efficacy testing, providing a more predictive and human-relevant model for preclinical drug development.

Key facts

At-a-glance profile data

Website
interobiosystems.com
Headquarters
Ann Arbor, United States
Founded
2024
Total funding
$2M (Pre-Seed)
Business model
B2B

Funding rounds

Funding rounds raised by Intero Biosystems
DateRoundAmountLead investors
11 Jun 2025Pre-Seed$2MKalamazoo Forward Ventures

Tech stack

Detected on interobiosystems.com, last scanned 23 Aug 2026. Run your own scan

Frontend
jQuery
CMS / Builders
WordPress
CDN
Cloudflare
Email provider
Mimecast
Add first review

Frequently asked

Is Intero Biosystems trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Intero Biosystems is 52 out of 100, based on site security posture and privacy practices.

How much funding has Intero Biosystems raised?

Intero Biosystems has raised a total of $2M in funding. The most recent round on record is Pre-Seed.